Medicinova (MNOV) Other Accumulated Expenses (2012 - 2025)
Medicinova (MNOV) posted quarterly Other Accumulated Expenses of $146540.0 for Q4 2025, up 15.54% year-over-year from $126832.0 in Q4 2024, and up 15.54% quarter-over-quarter from $126832.0 in Q4 2024.
Medicinova (MNOV) Other Accumulated Expenses (2012 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Other Accumulated Expenses for 14 consecutive years, with $146540.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 15.54% year-over-year to $146540.0; the TTM figure through Dec 2025 stood at $146540.0 (up 15.54% YoY), while the FY2025 annual figure was $146540.0, up 15.54% from the prior year.
- Other Accumulated Expenses grew to $146540.0 in Q4 2025 per MNOV's latest filing, from $126832.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $547270.0 in Q4 2021 and bottomed at $126832.0 in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $233823.4 across 5 years, with a median of $164375.0 in 2023.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses surged 441.62% — and 2022, when it sank 66.36%.
- Medicinova's Other Accumulated Expenses stood at $547270.0 in 2021, then tumbled by 66.36% to $184100.0 in 2022, then declined by 10.71% to $164375.0 in 2023, then retreated by 22.84% to $126832.0 in 2024, then increased by 15.54% to $146540.0 in 2025.
- Business Quant data shows MNOV's Other Accumulated Expenses at $146540.0 in Q4 2025, $126832.0 in Q4 2024, and $164375.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,540.00 |
| Dec 31, 2024 | 126,832.00 |
| Dec 31, 2023 | 164,375.00 |
| Dec 31, 2022 | 184,100.00 |
| Dec 31, 2021 | 547,270.00 |
| Dec 31, 2020 | 101,043.00 |
| Dec 31, 2019 | 354,707.00 |
| Dec 31, 2018 | 191,932.00 |
| Dec 31, 2017 | 141,504.00 |
| Dec 31, 2016 | 145,600.00 |
| Dec 31, 2015 | 158,559.00 |
| Dec 31, 2014 | 127,643.00 |
| Dec 31, 2013 | 102,094.00 |
| Sep 30, 2013 | 171,031.00 |
| Jun 30, 2013 | 169,372.00 |
| Dec 31, 2012 | 94,504.00 |